Growth factor treatment of demyelinating disease: At last, a leap into the light

Richard M. Ransohoff, Charles L. Howe, Moses Rodriguez

Research output: Contribution to journalReview article

36 Scopus citations


Researchers seeking treatments for multiple sclerosis (MS) have long dreamed of using neurotrophic factors to enhance remyelination. Previous attempts to apply trophic support for oligodendrocytes in experimental demyelination uniformly produced complicated outcomes that reflected unexpected effects on immune or inflammatory responses and could be interpreted only with caution. Now, two recent publications have demonstrated convincingly that cytokines of the interleukin (IL)-6 superfamily can ameliorate experimental autoimmune encephalomyelitis and promote oligodendrocyte survival, without demonstrable effect on inflammation or immune responses.

Original languageEnglish (US)
Pages (from-to)512-516
Number of pages5
JournalTrends in Immunology
Issue number11
StatePublished - Nov 1 2002


ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this